These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 31430695)

  • 1. Mycobacterium bovis sigF mutant exhibits altered surface phenotype and compromised pathogenesis.
    Dutta D; Srivastava V; Tripathi A; Singh V; Ansari MM; Pant G; Mishra M; Sharma S; Thota JR; Singh PK; Singh BN
    Tuberculosis (Edinb); 2019 Sep; 118():101855. PubMed ID: 31430695
    [No Abstract]   [Full Text] [Related]  

  • 2. Attenuation of late-stage disease in mice infected by the Mycobacterium tuberculosis mutant lacking the SigF alternate sigma factor and identification of SigF-dependent genes by microarray analysis.
    Geiman DE; Kaushal D; Ko C; Tyagi S; Manabe YC; Schroeder BG; Fleischmann RD; Morrison NE; Converse PJ; Chen P; Bishai WR
    Infect Immun; 2004 Mar; 72(3):1733-45. PubMed ID: 14977982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The extra cytoplasmic function sigma factor sigma(E) is essential for Mycobacterium tuberculosis virulence in mice.
    Manganelli R; Fattorini L; Tan D; Iona E; Orefici G; Altavilla G; Cusatelli P; Smith I
    Infect Immun; 2004 May; 72(5):3038-41. PubMed ID: 15102817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycobacterium tuberculosis ECF sigma factor sigC is required for lethality in mice and for the conditional expression of a defined gene set.
    Sun R; Converse PJ; Ko C; Tyagi S; Morrison NE; Bishai WR
    Mol Microbiol; 2004 Apr; 52(1):25-38. PubMed ID: 15049808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of virulence by disruption of the Mycobacterium tuberculosis erp gene.
    Berthet FX; Lagranderie M; Gounon P; Laurent-Winter C; Ensergueix D; Chavarot P; Thouron F; Maranghi E; Pelicic V; Portnoï D; Marchal G; Gicquel B
    Science; 1998 Oct; 282(5389):759-62. PubMed ID: 9784137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation of the principal sigma factor causes loss of virulence in a strain of the Mycobacterium tuberculosis complex.
    Collins DM; Kawakami RP; de Lisle GW; Pascopella L; Bloom BR; Jacobs WR
    Proc Natl Acad Sci U S A; 1995 Aug; 92(17):8036-40. PubMed ID: 7644534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Mycobacterium bovis double knockout mce2-phoP as candidate vaccine against bovine tuberculosis.
    García E; Bianco MV; Gravisaco MJ; Rocha RV; Blanco FC; Bigi F
    Tuberculosis (Edinb); 2015 Mar; 95(2):186-9. PubMed ID: 25620706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction and characterization of a Mycobacterium tuberculosis mutant lacking the alternate sigma factor gene, sigF.
    Chen P; Ruiz RE; Li Q; Silver RF; Bishai WR
    Infect Immun; 2000 Oct; 68(10):5575-80. PubMed ID: 10992456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of a sigma factor gene, sigF, affects an intermediate stage of spore pigment production in Streptomyces aureofaciens.
    Rezuchová B; Barák I; Kormanec J
    FEMS Microbiol Lett; 1997 Aug; 153(2):371-7. PubMed ID: 9271865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of Genome Region of Difference 4 (RD4) on Mycobacterial Virulence and BCG Efficacy.
    Ru H; Liu X; Lin C; Yang J; Chen F; Sun R; Zhang L; Liu J
    Front Cell Infect Microbiol; 2017; 7():239. PubMed ID: 28642843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycobacterium tuberculosis WhiB3 interacts with RpoV to affect host survival but is dispensable for in vivo growth.
    Steyn AJ; Collins DM; Hondalus MK; Jacobs WR; Kawakami RP; Bloom BR
    Proc Natl Acad Sci U S A; 2002 Mar; 99(5):3147-52. PubMed ID: 11880648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of methoxymycolic acid production by Mycobacterium bovis BCG vaccines.
    Belley A; Alexander D; Di Pietrantonio T; Girard M; Jones J; Schurr E; Liu J; Sherman DR; Behr MA
    Infect Immun; 2004 May; 72(5):2803-9. PubMed ID: 15102790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The adenylyl cyclase Rv2212 modifies the proteome and infectivity of Mycobacterium bovis BCG.
    Pedroza-Roldán C; Aceves-Sánchez Mde J; Zaveri A; Charles-Niño C; Elizondo-Quiroga DE; Hernández-Gutiérrez R; Allen K; Visweswariah SS; Flores-Valdez MA
    Folia Microbiol (Praha); 2015 Jan; 60(1):21-31. PubMed ID: 25038956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycobacterium bovis ESAT-6, CFP-10 and EspC antigens show high conservation among field isolates.
    Encinas M; Marfil MJ; Garbaccio S; Barandiaran S; Huertas P; Morsella C; Macías A; Magnano G; Zapata L; Bigi F; Cataldi A; Paolicchi F; Zumárraga M; Eirin ME
    Tuberculosis (Edinb); 2018 Jul; 111():143-146. PubMed ID: 30029900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anaerobic nitrate reductase (narGHJI) activity of Mycobacterium bovis BCG in vitro and its contribution to virulence in immunodeficient mice.
    Weber I; Fritz C; Ruttkowski S; Kreft A; Bange FC
    Mol Microbiol; 2000 Mar; 35(5):1017-25. PubMed ID: 10712684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the two component regulatory system PhoPR in Mycobacterium bovis.
    García EA; Blanco FC; Bigi MM; Vazquez CL; Forrellad MA; Rocha RV; Golby P; Soria MA; Bigi F
    Vet Microbiol; 2018 Aug; 222():30-38. PubMed ID: 30080670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of the putative antioxidant noxR1 does not alter the virulence of Mycobacterium tuberculosis H37Rv.
    Stewart GR; Ehrt S; Riley LW; Dale JW; McFadden J
    Tuber Lung Dis; 2000; 80(4-5):237-42. PubMed ID: 11052913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockout mutation of p27-p55 operon severely reduces replication of Mycobacterium bovis in a macrophagic cell line and survival in a mouse model of infection.
    Bianco MV; Blanco FC; Forrellad MA; Aguilar D; Campos E; Klepp LI; Hernández-Pando R; Cataldi AA; Bigi F
    Virulence; 2011; 2(3):233-7. PubMed ID: 21543883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti.
    Pym AS; Brodin P; Brosch R; Huerre M; Cole ST
    Mol Microbiol; 2002 Nov; 46(3):709-17. PubMed ID: 12410828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Mycobacterium tuberculosis mysB gene product is a functional equivalent of the Escherichia coli sigma factor, KatF.
    Mulder NJ; Powles RE; Zappe H; Steyn LM
    Gene; 1999 Nov; 240(2):361-70. PubMed ID: 10580156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.